- Research
- Nutritional & Dietary
- Multivitamins / Vitamin D / Folate
Do multivitamin and mineral supplements help autistic children?
What 7 sources say — one fair test, a mixed result, and why it is too early to tell.
A care note before you read. Vitamin and mineral pills are sold without a prescription, but they are not all the same. Different products have very different amounts of each vitamin. Please talk with your child’s doctor before starting one, especially if your child already takes other supplements or medicines.
Podcast·Two-voice deep dive
Listen to the discussion
Chapters & transcript
This is an AI-generated discussion of this article, transcribed automatically. The written summary below is the reviewed source — if the two differ, go by the summary.
0:00What is this discussion about?
Host A Right now, there are, I mean, parents all over the country who are buying these highly concentrated, over-the-counter vitamin pills for their autistic children.
Host B Right. And we are talking about doses that are, well, astronomically higher than your standard daily gummy vitamin.
Host A Exactly. But when you look past the marketing and, you know, past the theories and you actually look into the clinical data, the math just, it really doesn't add up the way you might expect.
Host B It rarely does when you start really digging into the underlying science. I mean, the surface-level claims can sound super promising, but as a listener trying to navigate all this, you really have to look at the structural integrity of the evidence itself.
Host A Yeah, and that is exactly what we are doing for you today as we welcome you to this deep dive. Today, our focus is squarely on multi-ingredient vitamin and mineral supplements specifically marketed for autistic children.
Host B Yes, and to understand what the science actually says, we are pulling from a very specific set of sources for you.
Host A Right. We're looking at a demo grade audit document and a findings report from the Spectrum Connect demo library.
Host B Which is really cool. You can think of this as a demo grade run of a highly rigorous tool designed to evaluate and just completely stress test scientific literature.
Host A Which is a crucial distinction for us to make right up front.
Host B Definitely. I mean, we aren't just reading study abstracts here. We are looking at how a strict clinical grading system processes the available data.
Host A Right. It exposes the strengths and, frankly, the glaring weaknesses of how this research was actually conducted.
Host B And because we are dealing with clinical data, we really have to start with a very clear, very crucial disclaimer.
Host A Yes. What we are doing today is summarizing research findings. This is not medical advice.
Host B Exactly.
Host A We're just mapping out what the science actually says, and we are not taking a side. Nothing discussed in this conversation is a recommendation for any individual child to take or avoid any supplement whatsoever.
Host B We're just unrolling the data and seeing exactly where it leads.
Host A Kind of like reading the blueprints of a building before deciding if it's safe to walk inside. We're just mapping it out.
Host B I love that analogy.
2:10What is a multivitamin and mineral supplement for autism?
Host B And where it leads is actually fascinating, especially when we clearly define what this intervention actually is.
Host A So what are we talking about here?
Host B Well, according to our sources, when we talk about a multi-ingredient vitamin and mineral supplement in this specific context, we are talking about a single pill or a powder. It contains a really broad spectrum of vitamins and minerals. And it's sold over the counter, meaning no prescription is required at all.
Host A Okay, I want to pause and expand on that immediately because when I hear the word vitamin, my mind just goes straight to the grocery store aisle.
Host B Right, of course.
Host A I picture the standard, brightly colored, Flintstones chewable vitamins that millions of kids take every single morning.
Host B Oh, yeah.
Host A But looking at the sources, that is absolutely not what we're talking about here, right? I mean, the dosages are on a completely different planet.
Host B They really are. And we need to emphasize why this specific dosage difference matters so much when looking at the research.
Host A Yeah.
Host B These are not standard daily multivitamins designed for general health maintenance. Some of the products formulated specifically for autism, the ones these studies evaluate, they contain much higher amounts of specific nutrients than standard daily allowances.
Host A Like how much higher?
Host B Well, for example, our sources note one formulation that contains 10 milligrams of vitamin B6 for a 60-pound child.
Wow.
Host A Which is a massive, highly concentrated dose for a body that size.
Host B Exactly.
Host A This isn't just like topping off a kid's nutrition. It is an intensive, targeted intervention.
Host B Right. And the theory behind this intervention, what the manufacturers claim it targets, is based on the idea of metabolic inefficiency.
Host A Okay, break that down for me.
Host B So the theory suggests that autistic children might not absorb or process or utilize certain nutrients efficiently through just a normal diet.
Host A Got it. So the logic is if there is a metabolic roadblock, a standard diet or a standard Flintstones vitamin just won't cut it.
Host B Exactly. You have to essentially flood the system with a highly concentrated broad spectrum supplement to bridge that gap.
Host A And by bridging that gap, they claim to improve core areas like behavior, sleep, and attention, right?
Host B That is the premise driving the intervention, yeah.
4:21How much research is there, and who was studied?
Host A Okay, so if that's the theory driving families to buy these products, how did the actual evidence base develop? Because looking at the landscape of the research we have in these sources, the foundation looks incredibly narrow.
Host B It is surprisingly limited when you isolate the rigorous trials. We basically have one main randomized controlled trial, where they actually compare a product to a dummy pill, of a multivitamin on its own.
Host A Just one?
Host B Yeah, that original trial was published by Adams in 2011. Then there was another major trial by the exact same group in 2018, but that one looked at a massive dietary package, not just the standalone pill.
Host A Okay, I want to highlight a huge red flag that jumped out at me in the audit. Both of those major trials, the only ones providing the core experimental data, come from the exact same research group at Arizona State University.
Host B Yes.
Host A Do we have any independent research teams that have successfully replicated this original work in the sources we captured?
Host B According to the audit document, no. Wow. Yeah, no independent teams have successfully replicated this original work in the captured sources. The experimental data is heavily localized to this one specific research group.
Host A Let's, I mean, outside of their work, what else is there?
Host B Outside of their work, we really only have a couple of non-randomized observational studies like Mehl-Madrona 2010 and Hussein 2023. Okay. And then we have systematic reviews like Shen 2025 and Yang 2026 from independent researchers who simply try to pool the existing data together to see if a pattern emerges. Right.
Host A Wait. So the two biggest trials come from the exact same research group. Independent teams haven't replicated it. And wait, what about the funding?
Host B Well, the sources note that the 2018 package trial was actually funded by families via an annual walk fundraiser.
Host A Okay. And didn't the audit mention some ties to commercial labs?
Host B Yes. The audit also flags that author affiliations include commercial labs, specifically naming vitamin diagnostics and doctor's data.
Host A Right.
Host B Now, the sources do note that the exact competing interest statements weren't fully captured in this specific demo run, but those affiliations are explicitly present in the documentation.
Host A Okay, that feels like a massive red flag we need to keep in mind. I mean, we have the two biggest trials from the same group, zero independent replication, funding from family fundraisers, and potential ties to commercial vitamin labs.
Host B It's a lot of context, yeah.
Host A It is. But let's put the origins aside for a second and look at who they actually studied. What did these studies actually measure? Like, let's take that 2011 Adams trial, the one looking at just the supplement pill.
Host B Well, the participant data is where the clinical evaluators really start to raise their eyebrows. They started by randomizing 141 people.
Host A Okay, 141.
Host B But right out of the gate, nearly a third of them dropped out or simply weren't evaluated in the final numbers.
Host A So they were left with what?
Host B They evaluated 53 in the supplement group and 51 in the placebo group, leaving incredibly small groups to compare.
Host A Wow.
Host B But the most crucial, frankly, baffling detail about these participants is the age range.
Host A What was it?
Host B The ages in this single data pool ranged from three years old all the way to 60 years old.
Host A Wait, I have to push back on that. Three to 60 in the exact same data pool?
Host B Yes. They completely mixed preschoolers, teenagers, and senior citizens into the exact same evaluation group.
Host A How do you even begin to measure success across that kind of gap? I mean, if you are trying to measure a behavioral change, say social withdrawal or irritability, a toddler throwing a tantrum is fundamentally different from a 60-year-old adult experiencing irritability. Completely different. Putting them on the same scale seems like it would make the data hopelessly murky. What tools were they even using to measure this stuff?
Host B That is a fundamental challenge of the study design. To measure these behavioral changes, the studies primarily relied on subjective parent or caregiver scales like the PGI-R, the PDD-BI, and the ATEC.
Host A Okay, so a lot of acronyms, but basically caregiver surveys.
Host B Exactly. They would ask the caregiver to rate specific behaviors before and after the intervention. They also used some clinician observation scales. And crucially, they used blood tests to look for biomarkers. Oh, and the Adams 2018 study also measured nonverbal IQ.
Host A Okay. And what was the timeline for all of this? Are we talking about a multi-year study to see how these high-dose vitamins affect a kid's long-term development?
Host B No, not at all. The main RCT from 2011, the one testing just the pill, was incredibly short. It lasted exactly three months.
Host A Three months? That's nothing.
Host B Right. The 2018 package study was longer, lasting 12 months. But crucially, the sources note that absolutely no long-term follow-up data exists post-study.
Host A So once the trial ended, that was it?
Host B That was it. We have no data on what happened to those participants long term.
Host A Okay. So knowing exactly how they measured success, relying on subjective parent surveys for a brief three-month window on a group that ranges from toddlers to senior citizens, I mean, that perfectly sets up the weirdly mixed bag of results they actually found.
Host B It really does.
9:43Did the vitamin pill help in the one fair test?
Host A Let's get into the findings. What actually happened in that 2011 trial?
Host B The results were definitively mixed. In that Adams 2011 trial, one single parent rating, the PGI-R, showed a positive difference. It was a 0.67 change for the supplement group versus a 0.34 change for the dummy pill group.
Host A Okay, so a tiny fraction of a point of improvement on one survey.
Host B Right. But more importantly, three other core autism scales used in that exact same study showed absolutely no significant group differences between the people taking the megadose vitamin and the people taking the placebo.
Host A So one survey showed a blip of improvement and three other major surveys said nothing changed at all. What about the blood tests? Did the biomarkers change?
Host B The blood tests were very clear. Blood levels of certain vitamins as well as ATP, which is a cellular energy marker, rose by up to 25 to 30 percent.
Host A Okay.
Host B The chemistry of the body measurably changed.
Host A Right, but here's where we have to look closely at what that actually means. Because a 30% increase in a biomarker sounds like a massive victory on a press release.
Host B Oh, absolutely.
Host A But biologically, all that really proves is that the participant swallowed a massive dose of vitamins and it successfully entered their bloodstream. It's like putting premium gas in a car. It proves the tank is full, but it doesn't automatically mean the car drives any better.
Host B That is precisely how rigorous clinical evaluators view it. And we'll dive into how they grade those biomarkers shortly.
11:12What about the 12-month program that added a diet and other supplements?
Host B But first, let's address the 2018 study.
Host A The 12-month one.
Host B Yeah, because that one made a much larger claim. They reported that nonverbal IQ went up 6.7 points in the treated group compared to a 0.6 drop in the control group.
Host A An IQ bump of nearly seven points sounds huge. But earlier you called this a package study. What does that actually mean in this context?
Host B It means it was a massive, sequential package. They didn't just give participants a vitamin pill and measure the results.
Host A What else did they do?
Host B Over the course of 12 months, they introduced vitamins, specialized fatty acids, Epsom salt baths, carnitine, digestive enzymes, and a strict gluten-free, casein-free diet, all layered on top of each other at once.
Host A Okay, this is where trying to extract scientific truth becomes impossible. It's like baking a cake with 20 different ingredients without a recipe.
Host B Exactly.
Host A If it tastes good, you have absolutely no idea which ingredient actually did the trick. And worse, you don't know if one of those hidden ingredients is going to give you a stomachache later.
Host B And that is exactly why independent reviewers are so critical of it.
12:20What do reviews that combine studies show?
Host B In fact, when independent researchers zoomed out and mathematically combined all the available multivitamin studies together in recent meta-analyses, the results were very telling.
Host A What did they find?
Host B Well, the 2025 review by Shen pooled the data and found a shockingly small overall effect size of just 0.19. And more importantly, the math showed that this tiny effect was not statistically significant.
Host A Meaning it could have just been zero.
Host B It could have been absolute zero, yes. And a 2026 review by Yang looked at 16 different trials of various nutritional supplements and concluded that the current evidence simply does not support recommending any specific supplement over a standard usual care.
13:02Are there side effects?
Host A We also need to talk about the physical reality of taking these pills. Did the sources report any adverse effects?
Host B Yes, they did. In the three-month trial, three people taking the high-dose supplement and five people on the placebo dropped out entirely due to side effects.
Host A Wow, okay.
Host B The studies reported mild, temporary effects, things like behavioral changes or loose stools. That affected about 11% of the people on the pill and 7% on the placebo.
Host A So you're looking at relatively similar mild digestive or behavioral issues?
Host B Yeah, in the short term.
13:36Why is the evidence rated very low?
Host A So if we step back and look at the whole board, we have a tiny fraction of a point of improvement on one survey, null results on three others, a completely muddy 12-month package study, and independent reviewers saying the statistical effect is basically zero. How does the audit document actually grade the strength of this evidence?
Host B the clinical grading tools are ruthless. The audit explicitly grades the certainty of this evidence as either very low or insufficient.
Host A Very low. They aren't sugarcoating it.
Host B Not at all. And it's because of the massive design weaknesses identified in the sources. We've already discussed the fatal flaw of mixing toddlers and adults in the same data pool.
Host A Right.
Host B But the clinical tools also severely penalize studies for missing data. In that Adams 2011 trial, the dropout numbers listed in the study simply do not match the final evaluation counts.
Host A Wait, really?
Host B Yeah. The math literally does not reconcile.
Host A And what about the 2018 package study, the one that claimed the IQ bump? How did that survive the audit?
Host B It didn't. The audit severely penalizes that 2018 study because it completely lacked a placebo control group.
Host A Wait, so the control group got nothing?
Host B The group that didn't get the intervention literally got nothing. They knew they weren't being treated.
Host A Which introduces a massive problem with expectation bias. I mean, if you are a parent and you spend 12 agonizing months giving your child highly restrictive diets, specialized fatty acids, and daily Epsom salt baths, aren't you naturally going to rate them higher on subjective surveys just because you desperately want it to work?
Host B Exactly. The placebo effect isn't just about the child's body. It's heavily influenced by the parent's perception when they are unblinded to the treatment. When parents know the allocation, and they are the ones filling out the surveys, the risk of bias skyrockets to an unacceptable level for clinical evaluators.
Host A Okay, so the evidence we do have is graded as very low certainty. But honestly, what concerns me more is what we don't know. What does this evidence absolutely fail to answer? Like, what are the gaping holes in the science here?
Host B The gaps are substantial. First, because of that 3 to 60 age range, we fundamentally do not have child-only results from the main RCT.
Host A Because it's hopelessly mixed with the adults.
Host B Exactly. Second, because of the cake-baking analogy you used for the 2018 study, we have absolutely no idea which part of that massive package actually moved the needle, if any of it did.
16:05Could high doses build up to too much over time?
Host A And we haven't even touched on the biggest gap of all, which is the physical safety of giving a small child mega doses of vitamins over a long period of time.
Host B This is perhaps the most glaring gap highlighted in the sources. We have to look at the biology of how vitamins work. Water-soluble vitamins like vitamin C are generally flushed out in your urine if you take too much. But fat-soluble vitamins like vitamins A and D operate differently.
Host A Right. They don't just flush out.
Host B No, they accumulate. They are stored in the liver and in fatty tissues.
Host A Meaning that over time, if you take too much, it just keeps building and building in your system.
Host B Precisely. And the sources specifically note that no study checked if these children were experiencing a toxic buildup of these fat-soluble vitamins. Wow. Furthermore, no study bothered to compare these specific highly concentrated formulation doses to the established tolerable upper intake level for children. That is a staggering oversight.
Host A A three-month trial is nowhere near long enough to determine if a fat-soluble vitamin is slowly building up to a toxic level in a developing kid's liver.
Host B It's an entirely open question. We have data on short-term, mild side effects like loose stools. But the vital question of long-term safety regarding vitamin buildup was simply never measured in the captured data.
Host A Let's put on our clinical evaluator hats for a second. We've talked about the flaws, but how do experts actually formalize this? The sources mention rigorous clinical grading rubrics that evaluators use, right?
Host B Yes, tools like AMSTAR 2 and RoB 2, which are mentioned in the sources. These are standard, highly rigorous tools designed specifically to assess the risk of bias in clinical trials.
Host A And how do they weigh this kind of evidence?
Host B When evaluators run these multivitamin studies through these tools, they severely downgrade their confidence in the result for the exact reasons we've discussed. If a trial relies on unblinded parent ratings where expectation bias can run wild, that is an immediate downgrade.
Host A Makes sense.
Host B If the attrition data, the dropouts, don't mathematically reconcile, that is a downgrade.
Host A And how do they handle those biomarkers, the blood tests that prove the vitamins entered the system?
Host B The clinical rubrics are incredibly strict about this. Evaluators firmly separate what they call target engagement biomarkers from actual clinical benefit.
Host A Okay.
Host B If you take a mega dose of vitamins and your blood levels of those vitamins rise, that is a target engagement biomarker. It proves the target was engaged. But evaluators expect that to happen based on basic biology. They absolutely do not grade a rise in blood vitamins as a behavioral benefit for autism.
Host A Right. It just proves the tank is full. It doesn't mean the car drives better.
Host B Exactly. And the rubrics are just as strict about stratification. Evaluators completely separate massive packages from single products.
Host A Right.
Host B They flatly refuse to give the standalone vitamin pill credit for the results of the 2018 study because specialized diets and fatty acids were all mixed in.
Host A Which means you can't ethically point to the 2018 study and say, you know, look, this vitamin pill raises IQ because the pill was never acting alone.
Host B Precisely. Once you run these studies through this strict clinical grading rubric, stripping away the marketing and the noise, the final takeaways become very clear.
19:31What are the key takeaways?
Host A All right, let's pull all of this together and recap the core takeaways for you, the listener. What are the key findings we've extracted from these sources today?
Host B Finding number one, only one fair test using a dummy pill has looked at a multivitamin and mineral pill on its own. While it showed a fraction of a point of improvement on one single parent rating, it showed zero clear difference on three other core autism scales.
Host A Okay, finding number two. independent reviewers zoomed out and combined multivitamin studies in a 2025 meta-analysis, the overall behavioral result was incredibly small and, importantly, not statistically significant.
Host B Finding number three is the major limitation. The evidence base driving this entire intervention is officially graded as very low certainty. It relies heavily on trials from a single research group that mixed children and adults together in the same data pool.
Host A And finding number four is the glaring open question. It is entirely unknown if these high-dose formulations exceed the tolerable upper intake levels for children, as long-term safety regarding the toxic buildup of fat-soluble vitamins was simply not measured in the captured data. So we've unrolled the blueprints, we've looked at the foundational data, and we've seen exactly where the science is lacking. But before we go, we must reiterate, decisions about any individual child belong in a conversation with that child's pediatrician or care team.
Host B Absolutely.
Host A This deep dive cannot make that call.
Host B It cannot.
Host A It is also important to note that research on this topic continues and that Spectrum Connect will update its coverage as new evidence appears. And as promised, here is a verbatim note directly from our sources. Spectrum Connect translates autism research into plain language for parents and checks findings for accuracy against misinformation. If you are a credentialed expert, MD, PhD, PsyD, or DO and would like to help validate our findings, email research@spectrumconnect.us.
Host B It is vital work.
Host A It really is. And I want to leave you with one final thought to mull over as we wrap up today. We talked about how those blood tests conclusively proved the vitamins entered the system, right? ATP and vitamin levels measurably rose.
Host B Yeah, the basic chemistry changed.
Host A But if you can measurably alter basic body chemistry markers like that, yet core behavioral symptoms don't clearly change across the board, what does that tell us about the incredibly complex, unpredictable relationship between basic biology and human behavior?
Host B It's a profound question.
Host A You can flood the system with nutrients. You can prove the biological tank is full. But maybe the way the human mind actually navigates the world is vastly more complicated than just tweaking a chemical input.
Host B Biology is the foundation, but behavior is the entire building.
Host A Exactly. Sometimes the raw materials just don't tell the whole story. Thanks for joining us on this deep dive.
Key Takeaways
Only one fair test has looked at a vitamin and mineral pill on its own — over 3 months, parents’ overall rating improved more on the pill than on a dummy pill (0.67 compared with 0.34). Three other autism scales did not show a clear difference.
Combining studies did not settle it — a 2025 review combined 2 multivitamin studies, and the combined result was small and could have been zero. Higher blood vitamin levels show the pill was taken in by the body, not that autism signs got better.
The one positive result has limits — it came from a single parent rating, the test included adults as well as children (ages 3 to 60), and both of the larger studies came from one research group. We could not check whether the researchers had a money link to the product.
Reviews of supplements as a group do not change this — a 2026 review of 16 fair tests said the evidence does not support recommending any supplement over usual care. It did not include a multivitamin group.
Amounts vary a lot between products, and too much was not studied — side effects in the 3-month test were mild and similar on the pill and the dummy pill. But we found no study that checked whether children got too much of vitamins that build up in the body, such as vitamins A and D.
What this means for you
A multivitamin and mineral supplement is one pill or powder with many vitamins and minerals in it. Some products made for autism have much more of some vitamins than a normal daily amount. Some people think autistic children may not get or use enough of some nutrients, and that a broad supplement could help with behavior, sleep or attention. This page is only about products with many vitamins and minerals together; single vitamins, such as vitamin D, vitamin B6 with magnesium, or folinic acid, are covered separately.
When we looked at what has actually been tested, only one fair test with a dummy pill had looked at such a pill on its own. Parents’ overall rating improved more on the pill, but three other autism scales did not show a clear difference. A 2025 review combined 2 multivitamin studies and found a small result that could have been zero. A 12-month program study added a vitamin and mineral pill, fatty acids, Epsom salt baths, carnitine, digestive enzymes and a gluten-free, casein-free diet, one after another. Nonverbal IQ went up 6.7 points in the treated group and down 0.6 points in the group with no treatment, but with many changes at once and no dummy treatment, we cannot tell which part mattered.
Side effects were mild and similar on the pill and the dummy pill in the 3-month test. Even so, we found no study that checked for too much of vitamins that build up in the body, and we could not see the full list of doses in the supplement that was tested.
Who was studied. The fair test followed 141 children and adults aged 3 to 60 for 3 months (a subset aged 5 to 16 was in Arizona). The program study followed 67 people aged 3 to 58 for 12 months. The studies mostly used parent ratings, autism rating scales and blood tests; one tested nonverbal IQ with a tester who did not know the group. We did not find results for longer use or results reported only for children.
Where the studies landed
Not enough research yet2 Points toward it helping
4 Mixed or inconclusive
1 Points against it helping
Tap any tile to read it. The 2019 review covers dietary supplements as a group and the 2026 review had no multivitamin group, so neither speaks to a multivitamin pill directly.
Points toward it helping2
Mixed or inconclusive4
Points against it helping1
Spectrum Connect reviews published research on interventions parents are exploring for their autistic children — so you can see where the evidence actually stands. No agenda, no selling, no cherry-picking. Just the studies, our method, and what it means for you.
See the research behind this
For anyone who wants to check our work · 7 sources
Where we looked
This review was built from a web-based scoping search, not a direct search of the research databases. PubMed and PMC were not used because of CAPTCHA blocks. A full search would cover PubMed/MEDLINE, Embase, APA PsycINFO, the Cochrane Library (CENTRAL), CINAHL, Epistemonikos and the trial registers (ClinicalTrials.gov, ANZCTR, EU CTR). Here is the PubMed search we set out for it.
("Vitamins"[MeSH] OR "Minerals"[MeSH] OR "Micronutrients"[MeSH]
OR multivitamin*[tiab] OR "vitamin/mineral"[tiab] OR micronutrient*[tiab]
OR "broad-spectrum"[tiab] OR EMPowerplus[tiab] OR "Daily Essential Nutrients"[tiab])
AND ("Autism Spectrum Disorder"[MeSH] OR autis*[tiab] OR "ASD"[tiab])
NOT (prenatal[tiab] OR maternal[tiab] OR pregnan*[tiab])
Run on PubMed →
That search has not yet been run across the databases, so there are no per-database counts. No protocol was registered in advance. The prenatal multivitamin question (maternal use and autism risk) is a prevention question and is out of scope.
What we did with what we found
This is not a full PRISMA flow: nothing was formally screened and the search cannot be reproduced. Of the 7 included sources, 5 were read from publisher or journal pages (one only in part) and 2 from abstracts only.
What the strongest evidence says
One fair test favored the pill on one parent rating (0.67 compared with 0.34). The 2025 review’s combined multivitamin result (0.19, 95% range −0.09 to 0.47) could have been zero.
No clear difference on three autism scales in the one fair test.
One 12-month study; nonverbal IQ went up 6.7 points in the treated group and down 0.6 in the untreated group, but there was no dummy treatment and many parts changed at once.
A 2010 non-randomized comparison and a 2023 study with no comparison group. Neither is a fair test with a dummy pill.
Mild side effects, similar on the pill and the dummy pill (3 and 5 people stopped because of side effects; about 11% and 7% had short, mild problems). In the program study, 2 people had worse behavior possibly due to the supplement. No source we read checked for too much of vitamins that build up in the body, and the full dose list was not captured.
Keep reading
What would you like to do?
Want to talk to a parent who’s been there?
We match you with families whose kid is like yours. Free, takes two minutes.
Heard of something we haven’t covered?Suggest an article
If another parent, a clinic or a video mentioned a therapy you can’t find here, tell us. We’ll read the research and review it next.
Suggest an articleThink we got something wrong?Report a factual error
We publish the whole record so it can be checked, and that only counts if we act on what you find. If a number looks wrong, a study is missing or has been retracted, or we’ve read a finding in a way the evidence doesn’t support, tell us.
You don’t need a research background to file one. “This doesn’t match what our doctor told us” is a useful report. Every one reaches a person: we reply within seven days, and within thirty we have either corrected the page or told you when we will. Substantive reports send the affected steps back through the protocol and need fresh sign-off before anything here changes.
Report a factual errorAre you a clinician or researcher?Review this article
If you have read this and the evidence holds up, you can sign off on it. We send you a personal review link where you confirm your credentials, and our team checks every review before anything is published. Once approved, your name and a link to your profile appear on this article.
Ask to review this